Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Transfusion
|
September 30, 1999
Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients
T J Legler, S W Eber, M Lakomek, et al.
BMC Nephrology
|
February 26, 2013
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation
Rutger J H Maas, Jeroen K J Deegens, Jan A J G van den Brand, et al.
Vox Sanguinis
|
May 18, 2004
Rhabdomyolysis in allogeneic peripheral blood stem cell donors
J Schanz, C Wolf, M Koehler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 30, 2017
Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report
Robin A Daanen, Rutger J H Maas, Rutger H T Koornstra, et al.
Transfusion
|
June 20, 1998
RHD genotyping in weak D phenotypes by multiple polymerase chain reactions
T J Legler, J H Maas, V Blaschke, et al.
Kidney International
|
January 10, 2014
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
Björn Meijers, Rutger J H Maas, Ben Sprangers, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes
Dirk J W den Braanker, Rutger J H Maas, Guido van Mierlo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Transfusion
|
September 30, 1999
Application of RHD and RHCE genotyping for correct blood group determination in chronically transfused patients
T J Legler, S W Eber, M Lakomek, et al.
BMC Nephrology
|
February 26, 2013
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation
Rutger J H Maas, Jeroen K J Deegens, Jan A J G van den Brand, et al.
Vox Sanguinis
|
May 18, 2004
Rhabdomyolysis in allogeneic peripheral blood stem cell donors
J Schanz, C Wolf, M Koehler, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 30, 2017
Nivolumab-associated Nephrotic Syndrome in a Patient With Renal Cell Carcinoma: A Case Report
Robin A Daanen, Rutger J H Maas, Rutger H T Koornstra, et al.
Transfusion
|
June 20, 1998
RHD genotyping in weak D phenotypes by multiple polymerase chain reactions
T J Legler, J H Maas, V Blaschke, et al.
Kidney International
|
January 10, 2014
The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis
Björn Meijers, Rutger J H Maas, Ben Sprangers, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes
Dirk J W den Braanker, Rutger J H Maas, Guido van Mierlo, et al.
Page
of 2